Challenges of kidney transplantation in HIV positive recipients.

Human immunodeficiency virus (HIV) infection has long been a contraindication to kidney transplantation due to transplant immunosuppression, HIV-associated renal dysfunction, and nephrotoxicity associated with antiretroviral therapy (ART). However, advances in antiretroviral therapies and transplant immunosuppression regimens have allowed patients to successfully undergo kidney transplantation. Emerging data has shown that kidney transplantation may be a viable option for appropriately selected HIV patients with end-stage renal disease (ESRD). In this review, we discuss the indications, immunosuppression protocols, and outcomes of kidney transplantation in HIV patients.

• Publication year

  2019

• Venue

  Translational Andrology and Urology

• Publication date

  2019-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.21037/TAU.2018.11.09PMID 31080775PMCID PMC6503226
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Belatacept Conversion in an HIV‐Positive Kidney Transplant Recipient With Prolonged Delayed Graft Function

  2016cited by this paper
• Influence of immune activation on the risk of allograft rejection in human immunodeficiency virus-infected kidney transplant recipients.

  2016cited by this paper
• Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus–Infected Kidney Allograft Recipients

  2016cited by this paper
• Impact of antiretroviral therapy on clinical outcomes in HIV + kidney transplant recipients: Review of 58 cases

  2016cited by this paper
• De Novo Belatacept in a Human Immunodeficiency Virus–Positive Kidney Transplant Recipient

  2016cited by this paper
• Influence of the timing of antiretroviral therapy on the potential for normalization of immune status in human immunodeficiency virus 1-infected individuals.

  2015cited by this paper
• Immunosuppression Regimen and the Risk of Acute Rejection in HIV-Infected Kidney Transplant Recipients

  2014cited by this paper
• Surgical complications in 275 HIV-infected liver and/or kidney transplantation recipients.

  2012cited by this paper
• Renal transplantation in HIV-infected patients: 2010 update.

  2011cited by this paper
• Acute HIV-1 Infection.

  2011cited by this paper
• Renal Transplantation in HIV‐Infected Patients: The Paris Experience

  2010cited by this paper
• Outcomes of kidney transplantation in HIV-infected recipients.

  2010cited by this paper
• [AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)].

  2010cited by this paper
• Safety and Efficacy of Raltegravir in HIV‐Infected Transplant Patients Cotreated with Immunosuppressive Drugs

  2009cited by this paper
• Antiretroviral treatment of adult HIV infection: 2010 recommendations of the International AIDS Society-USA panel.

  2008cited by this paper
• Preliminary Experience With Renal Transplantation in HIV+ Recipients: Low Acute Rejection and Infection Rates

  2008cited by this paper
• HIV‐Infected Liver and Kidney Transplant Recipients: 1‐ and 3‐Year Outcomes

  2008cited by this paper
• Guidelines for kidney transplantation in patients with HIV disease *

  2006cited by this paper
• HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy.

  2006cited by this paper
• Microbial translocation is a cause of systemic immune activation in chronic HIV infection

  2006cited by this paper
• HAART-related nephropathies in HIV-infected patients.

  2005cited by this paper
• [GESIDA/GESITRA-SEIMC, PNS and ONT consensus document on solid organ transplant (SOT) in HIV-infected patients in Spain (March, 2005)].

  2005cited by this paper
• Sirolimus for Kaposi's sarcoma in renal-transplant recipients.

  2005cited by this paper
• Safety and success of kidney transplantation and concomitant immunosuppression in HIV-positive patients.

  2005cited by this paper
• Solid organ transplantation in the HIV‐infected patient

  2004cited by this paper
• Human immunodeficiency virus infection and kidney transplantation in the era of highly active antiretroviral therapy and modern immunosuppression.

  2004cited by this paper
• Antiretroviral and immunosuppressive drug-drug interactions: an update.

  2004cited by this paper
• Effect of Mycophenolate Mofetil on the Pharmacokinetics of Antiretroviral Drugs and on Intracellular Nucleoside Triphosphate Pools

  2004cited by this paper
• Living-Related Donor Renal Transplantation in HIV+ Recipients using Alemtuzumab Preconditioning and Steroid-Free Tacrolimus Monotherapy: A Single Center Preliminary Experience

  2004cited by this paper
• Review of transplantation in HIV patients during the HAART era.

  2004cited by this paper
• Kidney and liver transplantation in human immunodeficiency virus-infected patients: a pilot safety and efficacy study1

  2003cited by this paper
• Determinants of survival among HIV-infected chronic dialysis patients.

  2003cited by this paper
• The interaction between antiretroviral agents and tacrolimus in liver and kidney transplant patients

  2002cited by this paper
• Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir.

  2002cited by this paper
• Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection.

  2001cited by this paper
• Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients.

  2000cited by this paper
• Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

  2000cited by this paper
• European Best Practice Guidelines for Renal Transplantation (part 1).

  2000cited by this paper
• Is the Prevalence of HIV-Associated Nephropathy Decreasing?

  1999cited by this paper
• Renal transplantation in patients positive for hepatitis B or C (con).

  1998cited by this paper
• Should all human immunodeficiency virus-infected patients with end-stage renal disease be excluded from transplantation? The views of U.S. transplant centers.

  1998cited by this paper
• OKT3 treatment for allograft rejection is a risk factor for cytomegalovirus disease in liver transplantation.

  1995cited by this paper
• Factors influencing the occurrence of active cytomegalovirus (CMV) infections after organ transplantation

  1993cited by this paper
• The risk of infection following OKT3 and antilymphocyte globulin treatment for renal transplant rejection: results of a single center prospectively randomized trial.

  1992cited by this paper
• THE CLINICAL AND PATHOLOGICAL COURSE OF HEPATITIS B LIVER DISEASE IN RENAL TRANSPLANT RECIPIENTS

  1984cited by this paper
• Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

  1984cited by this paper
• Renal disease in patients with AIDS: a clinicopathologic study.

  1984cited by this paper
• Glomerular lesions in the acquired immunodeficiency syndrome.

  1984cited by this paper

• Pharmacotherapeutic Interventions in People Living With HIV Undergoing Solid Organ Transplantation: A Scoping Review

  2023cites this paper
• Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV

  2020cites this paper
• The Role of the General Nephrologist in Evaluating Patients for Kidney Transplantation: Core Curriculum 2020.

  2020cites this paper
• Pharmacotherapeutic options for kidney disease in HIV positive patients

  2020cites this paper
• Evaluation of kidney recipients and donors for transplantation

  2020cites this paper